Search

Your search keyword '"Roobol, Monique J."' showing total 1,943 results

Search Constraints

Start Over You searched for: Author "Roobol, Monique J." Remove constraint Author: "Roobol, Monique J."
1,943 results on '"Roobol, Monique J."'

Search Results

101. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

102. Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data

105. Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.

106. Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?

107. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs.

108. Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.

111. How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

112. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

114. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

115. External validation of the Rotterdam Prostate Cancer Risk Calculator within a Dutch high-risk clinical cohort

118. Supplementary Materials and Methods from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

119. Supplementary Figure Legends from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

120. Supplementary Tables 1 through 8 and Supplementary Figures 1 through 15 from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

121. Data from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

122. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

123. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer : a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

124. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men

125. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer:Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs

126. Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy

127. A literature review to understand health literacy in men with prostate cancer on active surveillance

128. How to follow the new EU Council recommendation and improve prostate cancer early detection:the Prostaforum 2022 declaration

129. Active Surveillance for Prostate Cancer:Past, Current, and Future Trends

130. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death:Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

131. A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer:21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer

132. The Patient Journey from Randomization to Detection of Prostate Cancer and Death:Results from ERSPC Rotterdam

133. Prostate cancer risk assessment by the primary care physician and urologist:transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

134. Mapping European Association of Urology Guideline Practice Across Europe:An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

135. Shifting risk-stratified early prostate cancer detection to a primary healthcare setting

136. Interaction of MRI and active surveillance in prostate cancer:Time to re-evaluate the active surveillance inclusion criteria

137. Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's 'big data for better outcomes' program

138. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

141. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

143. Publisher Correction: Shared heritability and functional enrichment across six solid cancers

144. Shared heritability and functional enrichment across six solid cancers

145. Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

146. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men

147. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Catalog

Books, media, physical & digital resources